Facebook tracking pixel
K82.8
ICD-10-CM
Adenomyomatosis of the Gallbladder

Adenomyomatosis of the gallbladder, also known as gallbladder adenomyomatosis or gallbladder wall thickening with Rokitansky-Aschoff sinuses (RAS), is a benign condition characterized by hyperplasia of the gallbladder wall. This page provides information on diagnosis, clinical features, and medical coding for adenomyomatosis, including ICD-10 codes and related healthcare documentation terminology. Learn about the management and treatment options for gallbladder adenomyomatosis and its differential diagnosis.

Also known as

Gallbladder Adenomyomatosis
Gallbladder Wall Thickening with RAS

Diagnosis Snapshot

Key Facts
  • Definition : Benign thickening of the gallbladder wall due to muscle overgrowth and mucosal pockets (Rokitansky-Aschoff sinuses).
  • Clinical Signs : Often asymptomatic. May cause right upper quadrant pain, nausea, vomiting, similar to gallstones.
  • Common Settings : Detected incidentally on abdominal ultrasound or other imaging studies.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC K82.8 Coding
K82.8

Other specified diseases of gallbladder

This code encompasses other specified gallbladder diseases, including adenomyomatosis.

K80-K87

Diseases of the gallbladder, biliary tract

Covers various gallbladder and biliary tract disorders, including inflammatory and other conditions.

K81.1

Cholesterolosis of gallbladder

While distinct, cholesterolosis shares some gallbladder wall changes with adenomyomatosis.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the diagnosis Adenomyomatosis of the Gallbladder?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Gallbladder wall thickening with Rokitansky-Aschoff sinuses
Gallbladder polyps, cholesterol
Gallbladder wall thickening, unspecified

Documentation Best Practices

Documentation Checklist
  • Document gallbladder wall thickening characteristics.
  • Specify location and extent of Rokitansky-Aschoff sinuses (RAS).
  • Note presence/absence of intramural diverticula.
  • Differentiate from other gallbladder pathologies (e.g., cholesterolosis, cancer).
  • Correlate ultrasound or other imaging findings with diagnosis.

Coding and Audit Risks

Common Risks
  • RAS/Rokitansky-Aschoff Sinus Misinterpretation

    Confusing RAS presence with other conditions like gallbladder wall thickening or cholecystitis, leading to inaccurate coding.

  • Adenomyomatosis Specificity

    Failing to specify segmental or diffuse adenomyomatosis, affecting accurate diagnosis and procedure coding.

  • Coding with Complicating Cholelithiasis

    Incorrectly coding adenomyomatosis with cholelithiasis when stones are incidental or unrelated, impacting reimbursement and data accuracy.

Mitigation Tips

Best Practices
  • Document RAS or Rokitansky-Aschoff sinuses for accurate coding.
  • Code K82.8 for adenomyomatosis; specify segmental/diffuse.
  • Query physician to differentiate from gallbladder cancer.
  • Correlate imaging findings with symptoms for medical necessity.
  • Ensure clear documentation for compliance with coding guidelines.

Clinical Decision Support

Checklist
  • 1. Verify diffuse or segmental GB wall thickening on imaging.
  • 2. Check for Rokitansky-Aschoff sinuses (RAS) or diverticula.
  • 3. Evaluate for comet-tail artifacts or intramural cysts.
  • 4. Correlate imaging findings with symptoms (e.g., biliary pain).
  • 5. Exclude gallbladder carcinoma using clinical and imaging features.

Reimbursement and Quality Metrics

Impact Summary
  • Adenomyomatosis of the Gallbladder reimbursement impacts depend on accurate coding distinguishing it from other gallbladder diseases. Proper ICD-10-CM (K82.8) and CPT coding ensures appropriate claim submission and reduces denials. Optimize medical billing for maximum reimbursement.
  • Quality metrics related to gallbladder disease management are affected by accurate diagnosis coding for Adenomyomatosis. Clear documentation supporting K82.8 or related codes like RokitanskyAschoff sinuses (RAS) impacts hospital reporting and quality scores.
  • Miscoding Adenomyomatosis as cholecystitis can impact reimbursement and hospital quality data. Specificity in coding and documentation is crucial. Accurate coding improves healthcare analytics and resource allocation.
  • Adenomyomatosis coding accuracy affects Case Mix Index (CMI) and hospital reimbursement. Correctly coding K82.8 with supporting documentation ensures appropriate severity reflection for accurate payment.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the key differentiating features between adenomyomatosis of the gallbladder and gallbladder cancer on imaging?

A: Differentiating adenomyomatosis of the gallbladder from gallbladder cancer, particularly on imaging, can be challenging due to overlapping features. Adenomyomatosis typically presents with mural thickening, Rokitansky-Aschoff sinuses (RAS), and comet-tail artifacts on ultrasound. Gallbladder cancer, however, may demonstrate irregular or asymmetrical wall thickening, a large intramural mass, lymph node enlargement, and liver invasion. While comet-tail artifacts can be seen in adenomyomatosis, their presence doesn't exclude malignancy. Furthermore, the presence of RAS alone isn't definitive for adenomyomatosis, as cancer can sometimes arise within these sinuses. Consider implementing a multi-modality imaging approach, including ultrasound, CT, and MRI, to enhance diagnostic accuracy. Explore how incorporating contrast-enhanced ultrasound or MRI can aid in differentiating malignant features like neovascularization. For cases with indeterminate findings, biopsy or surgical consultation may be warranted. Learn more about the latest guidelines for gallbladder cancer management and surveillance.

Q: When is surgical intervention indicated for adenomyomatosis of the gallbladder, and how do I counsel patients on the risks and benefits?

A: Surgical intervention for adenomyomatosis of the gallbladder is typically not necessary unless the patient is symptomatic. Symptoms such as biliary colic, right upper quadrant pain mimicking gallstones, or recurrent episodes of cholecystitis may indicate a need for cholecystectomy. When counseling patients, clearly explain that asymptomatic adenomyomatosis itself rarely progresses to cancer. However, it is important to emphasize that adenomyomatosis and gallbladder cancer can coexist, and any new or changing symptoms warrant further investigation. Discuss the risks and benefits of surgery, including the potential for complications such as bleeding, infection, bile duct injury, and the need for conversion to open surgery. Conversely, highlight the benefits of laparoscopic cholecystectomy for symptomatic relief and the elimination of potential diagnostic uncertainty. Consider implementing a shared decision-making approach, tailoring the discussion to individual patient preferences and risk tolerance. Explore how pre-operative imaging and clinical evaluation can help guide surgical decision-making in complex cases.

Quick Tips

Practical Coding Tips
  • Code K82.8 for adenomyomatosis
  • RAS thickening? Verify location
  • Document ROKITANSKY-ASCHOFF sinuses
  • Exclude malignancy, code accordingly
  • Consider ultrasound findings for dx

Documentation Templates

Patient presents with symptoms suggestive of gallbladder adenomyomatosis, including intermittent right upper quadrant pain, bloating, and dyspepsia.  Differential diagnoses considered include cholelithiasis, chronic cholecystitis, and gallbladder polyps.  Physical examination reveals mild tenderness in the right upper quadrant.  Ultrasound imaging of the gallbladder demonstrates diffuse or segmental gallbladder wall thickening with Rokitansky-Aschoff sinuses (RAS), a hallmark finding of adenomyomatosis.  Comet-tail artifacts, another characteristic sonographic feature, may be present.  No gallstones or gallbladder sludge were visualized.  The patient's symptoms are attributed to gallbladder dysmotility associated with the adenomyomatosis.  Conservative management with dietary modifications, including a low-fat diet, is recommended initially.  Patient education regarding the benign nature of this condition and the potential for symptom recurrence was provided.  Follow-up ultrasound is scheduled in six months to monitor for any changes.  Surgical intervention, such as cholecystectomy, is not currently indicated given the absence of complications such as recurrent acute cholecystitis or suspicion of malignancy.  The diagnosis of gallbladder adenomyomatosis with RAS was discussed with the patient, and they understand the management plan.  ICD-10 code K82.8 is documented for other specified diseases of gallbladder.